No results for ‘’
Jagsonpal Pharmaceuticals Ltd
NSE: JAGSNPHARM BSE: 507789
₹225.47
(2.39%)
Mon, 17 Aug 2026, 01:25 pm
Market Cap (in Cr)1518.03
PE Ratio33.65
Dividend1.09
Jagsonpal Pharmaceuticals Ltd About
Jagsonpal Pharmaceuticals engaged in the business of manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients.
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
1978
Headquarters
CEO
Harsha Raghavan
Employees
Contact
Website
http://www.jagsonpal.com
skmata@jagsonpal.com; cs@jagsonpal.com
Phone
91-011-46181100/46109900
Location
T-210 J, Shahpur Jat, New Delhi, New Delhi, 110049